From Surf Wiki (app.surf) — the open knowledge base
List of largest pharmaceutical settlements
none
none
The following is a list of the 20 largest settlements reached between the United States Department of Justice and pharmaceutical companies from 2001 to 2013, ordered by the size of the total settlement. The settlement amount includes both the civil (False Claims Act) settlement and criminal fine. Glaxo's $3 billion settlement included the largest civil False Claims Act settlement on record, With respect to off-label promotion, specifically, a federal court recognized off-label promotion as a violation of the False Claims Act for the first time in Franklin v. Parke-Davis, leading to a $430 million settlement.
| Year | Company | Settlement | Violation(s) | Product(s) | Laws violated | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| (if applicable) | ||||||||||
| 2012 | date=2 July 2012 | title=GlaxoSmithKline to Plead Guilty and Pay $3 Billion to Resolve Fraud Allegations and Failure to Report Safety Data | url=https://www.justice.gov/opa/pr/2012/July/12-civ-842.html | url-status=live | archive-url=https://web.archive.org/web/20240714112314/https://www.justice.gov/opa/pr/glaxosmithkline-plead-guilty-and-pay-3-billion-resolve-fraud-allegations-and-failure-report | archive-date=2024-07-14 | accessdate=25 August 2012 | publisher=justice.gov}} | $3 billion ($1B criminal, $2B civil) | Criminal: Off-label promotion, failure to disclose safety data. |
| Civil: paying kickbacks to physicians, making false and misleading statements concerning the safety of Avandia, reporting false best prices and underpaying rebates owed under the Medicaid Drug Rebate Program | Avandia (not providing safety data), Wellbutrin, Paxil (promotion of paediatric use), Advair, Lamictal, Zofran, Imitrex, Lotronex, Flovent, Valtrex | False Claims Act, FDCA | ||||||||
| 2009 | url=https://www.justice.gov/opa/pr/justice-department-announces-largest-health-care-fraud-settlement-its-history | title=Justice Department Announces Largest Health Care Fraud Settlement in Its History | publisher=justice.gov | date=2 September 2009 | accessdate=12 June 2024}} | $2.3 billion | Off-label promotion, kickbacks | Bextra, Geodon, Zyvox, Lyrica | False Claims Act, FDCA | |
| 2013 | url=https://www.justice.gov/opa/pr/johnson-johnson-pay-more-22-billion-resolve-criminal-and-civil-investigations | title=Johnson & Johnson to Pay More Than $2.2 Billion to Resolve Criminal and Civil Investigations | publisher=justice.gov | date=4 November 2013 | accessdate=5 March 2015}} | $2.2 billion | Off-label promotion, kickbacks | Risperdal, Invega, Nesiritide | False Claims Act, FDCA | |
| 2012 | Abbott Laboratories | $1.5 billion | Off-label promotion | Depakote | False Claims Act, FDCA | |||||
| 2009 | Eli Lilly | $1.4 billion | Off-label promotion | Zyprexa | False Claims Act, FDCA | |||||
| 2001 | TAP Pharmaceutical Products | $875 million | Medicare fraud, kickbacks | Lupron | False Claims Act, Prescription Drug Marketing Act | |||||
| 2012 | Amgen | $762 million | Off-label promotion, kickbacks | Aranesp | False Claims Act, FDCA | |||||
| 2010 | GlaxoSmithKline | $750 million | Poor manufacturing practices | Kytril, Bactroban, Paxil CR, Avandamet | False Claims Act, FDCA | |||||
| 2005 | Serono | $704 million | Off-label promotion, kickbacks, monopolistic practices | Serostim | False Claims Act | |||||
| 2008 | Merck | $650 million | Medicare fraud, kickbacks | Zocor, Vioxx, Pepsid | False Claims Act, Medicaid Rebate Statute | |||||
| 2007 | Purdue Pharma | $601 million | Off-label promotion | Oxycontin | False Claims Act | |||||
| 2010 | Allergan | $600 million | Off-label promotion | Botox | False Claims Act, FDCA | |||||
| 2010 | AstraZeneca | $520 million | Off-label promotion, kickbacks | Seroquel | False Claims Act | |||||
| 2007 | Bristol-Myers Squibb | $515 million | Off-label promotion, kickbacks, Medicare fraud | Abilify, Serzone | False Claims Act, FDCA | |||||
| 2002 | Schering-Plough | $500 million | Poor manufacturing practices | Claritin | FDA Current Good Manufacturing Practices | |||||
| 2006 | Mylan | $465 million | Misclassification under the Medicaid Drug Rebate Program | EpiPen (epinephrine) | False Claims Act | |||||
| 2006 | Schering-Plough | $435 million | Off-label promotion, kickbacks, Medicare fraud | Temodar, Intron A, K-Dur, Claritin RediTabs | False Claims Act, FDCA | |||||
| 2004 | Pfizer | $430 million | Off-label promotion | Neurontin | False Claims Act, FDCA | |||||
| 2008 | Cephalon | $425 million | Off-label promotion | Actiq, Gabitril, Provigil | False Claims Act, FDCA | |||||
| 2010 | Novartis | $423 million | Off-label promotion, kickbacks | Trileptal | False Claims Act, FDCA | |||||
| 2003 | AstraZeneca | $355 million | Medicare fraud | Zoladex | Prescription Drug Marketing Act | |||||
| 2004 | Schering-Plough | $345 million | Medicare fraud, kickbacks | Claritin | False Claims Act, Anti-Kickback Statute |
References
References
- Medicare and Medicaid fraud]], [[Off-label use. off-label]] promotion, and inadequate manufacturing practices.Almashat, S ''et al''. [http://www.citizen.org/documents/rapidlyincreasingcriminalandcivilpenalties.pdf Rapidly Increasing Criminal and Civil Monetary Penalties Against the Pharmaceutical Industry: 1991 – 2010]. Public Citizen’s Health Research Group. December 16, 2010
- Katie Thomas, Michael S. Schmidt. (2 July 2012). "Glaxo Agrees to Pay $3 Billion in Fraud Settlement". [[The New York Times]].
- Lavoie, Denise. (5 December 2007). "Drug Whistleblower Collects $24M". cbsnews.com.
- (2 July 2012). "GlaxoSmithKline to Plead Guilty and Pay $3 Billion to Resolve Fraud Allegations and Failure to Report Safety Data". justice.gov.
- formed in 2000 by merger of Glaxo Wellcome and SmithKline Beecham
- (2 September 2009). "Justice Department Announces Largest Health Care Fraud Settlement in Its History". justice.gov.
- (4 November 2013). "Johnson & Johnson to Pay More Than $2.2 Billion to Resolve Criminal and Civil Investigations". justice.gov.
- (7 May 2012). "Abbott Labs to Pay $1.5 Billion to Resolve Criminal & Civil Investigations of Off-label Promotion of Depakote". justice.gov.
- (15 January 2009). "Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-label Promotion of Zyprexa". justice.gov.
- (3 October 2001). "TAP Pharmaceutical Products Inc. and Seven Others Charged with Health Care Crimes; Company Agrees to Pay $875 Million to Settle Charges". justice.gov.
- (19 December 2012). "Amgen Inc. Pleads Guilty to Federal Charge in Brooklyn, NY.; Pays $762 Million to Resolve Criminal Liability and False Claims Act Allegations". justice.gov.
- (26 October 2010). "GlaxoSmithKline to Plead Guilty & Pay $750 Million to Resolve Criminal and Civil Liability Regarding Manufacturing Deficiencies at Puerto Rico Plant". justice.gov.
- (17 October 2005). "Serono to Pay $704 Million for the Illegal Marketing of AIDS Drug". justice.gov.
- (7 February 2008). "Merck to Pay More than $650 Million to Resolve Claims of Fraudulent Price Reporting and Kickbacks". justice.gov.
- (7 November 2008). "Office of the Deputy Attorney General". justice.gov.
- (1 September 2010). "Allergan Agrees to Plead Guilty and Pay $600 Million to Resolve Allegations of Off-Label Promotion of Botox®". justice.gov.
- (27 April 2010). "Pharmaceutical Giant AstraZeneca to Pay $520 Million for Off-label Drug Marketing". justice.gov.
- (28 September 2007). "Bristol-Myers Squibb to Pay More Than $515 Million to Resolve Allegations of Illegal Drug Marketing and Pricing". justice.gov.
- (18 May 2002). "$500 million fine for Schering-Plough". [[The Philadelphia Inquirer]].
- (October 7, 2016). "For ripping off Medicaid, EpiPen maker Mylan pays Feds $465 million".
- (29 August 2006). "Schering to Pay $435 Million for the Improper Marketing of Drugs and Medicaid Fraud". justice.gov.
- (13 May 2004). "Warner-Lambert to Pay $430 Million to Resolve Criminal & Civil Health Care Liability Relating to Off-Label Promotion". United States Department of Justice.
- (29 September 2008). "Biopharmaceutical Company, Cephalon, to Pay $425 Million & Enter Plea to Resolve Allegations of Off-Label Marketing".
- (30 September 2010). "Novartis Pharmaceuticals Corporation, a US subsidiary of Novartis AG, reaches settlement agreement with US Attorney's Office". novartis.com.
- Petersen, Melody. (21 June 2003). "AstraZeneca Pleads Guilty In Cancer Medicine Scheme". nytimes.com.
- (30 July 2004). "Schering-Plough to Pay $345 Million to Resolve Criminal and Civil Liabilities for Illegal Marketing of Claritin". justice.gov.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about List of largest pharmaceutical settlements — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report